Dergiler / Konya Journal of Engineering Sciences / 2023 / Cilt: 11 Sayı: 4

A COMPARATIVE STUDY OF RELEASE KINETICS BEHAVIOR MODELS AND SHELF LIFE ASSESSMENT OF BACITRACIN ZINC-LOADED PLA COMPOSITES

Sayfa
1006–1015
Yayın Tarihi
2023-12-01
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Python programming was employed to model the release behavior and estimate the shelf life of Bacitracin Zinc (0.5, 1.0, and 2.0) incorporated into the PLA matrix to compare different weight percentages' behavior and shelf life.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Mathematical modeling aims to simplify the complex process of drug release and to gain knowledge about the release mechanisms specific to a given material system.
📊
Temel Bulgular & Veri:This study focused on fabricating PLA composites with different weight percentages of Bacitracin Zinc (0.5, 1.0, and 2.0) and evaluating their potential as a drug delivery system.
💡
Sonuç & Katkı:Python programming was employed to model the release behavior and estimate the shelf life of Bacitracin Zinc (0.5, 1.0, and 2.0) incorporated into the PLA matrix to compare different weight percentages' behavior and shelf life.
🔬Tür:Modelleme & Sayısal Simülasyon
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Bacitracin Zinc · Composite · PLA

Abstract

Mathematical modeling aims to simplify the complex process of drug release and to gain knowledge about the release mechanisms specific to a given material system. Consequently, a mathematical model focuses primarily on one or two important factors. Drug release aims to maximize the bioactivity of both naturally derived and synthetically derived macromolecules, thus increasing their clinical applicability and improving the overall quality of life. This study focused on fabricating PLA composites with different weight percentages of Bacitracin Zinc (0.5, 1.0, and 2.0) and evaluating their potential as a drug delivery system. To understand the release mechanism of Bacitracin Zinc from the PLA composites, we developed a Franz diffusion kinetic model and a mathematical model for cumulative release kinetics. The Franz diffusion model was utilized to analyze the release behavior of the PLA/Bacitracin Zinc composite structure. The results indicated a sustained release rate, following a Zero Order release kinetics pattern. Furthermore, the shelf life of the composite structure was determined to be 125 days. Python programming was employed to model the release behavior and estimate the shelf life of Bacitracin Zinc (0.5, 1.0, and 2.0) incorporated into the PLA matrix to compare different weight percentages' behavior and shelf life.

🔖

Bu Makaleye Atıf Yap

ÖZARSLAN, A. C., ÇİFTÇİ, F. (2023). A COMPARATIVE STUDY OF RELEASE KINETICS BEHAVIOR MODELS AND SHELF LIFE ASSESSMENT OF BACITRACIN ZINC-LOADED PLA COMPOSITES. Konya Journal of Engineering Sciences, Cilt: 11 Sayı: 4, 1006–1015. https://ajindex.com/articles/1019765

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (5)

  1. D. Y. Arifin, L. Y. Lee, and C. H. Wang, “Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems,” Advanced Drug Delivery Reviews, vol. 58, no. 12-13, pp. 1274-1325, 2006, doi: 10.1016/j.addr.2006.09.007. O. Pillai and R. Panchagnula, “Polymers in drug delivery,” Current Opinion in Chemical Biology. vol. 5, no. 4, pp. 447-451, 2001, doi: 10.1016/S1367-5931(00)00227-1.
  2. M. Chasin and R. Langer, Eds., Biodegradable polymers as drug delivery systems. New York: Marcel Dekker, 1990. J. Siepmann and F. Siepmann, “Mathematical modeling of drug delivery,” International Journal of Pharmaceutics, vol. 364, no. 2, pp. 328-343, 2008, doi: 10.1016/j.ijpharm.2008.09.004. S. B. Lin, K. S. Hwang, S. Y. Tsay, and S. L. Cooper, “Segmental orientation studies of polyether polyurethane block copolymers with different hard segment lengths and distributions,” Colloid Polym. Sci., vol. 263, pp. 128-140, 1985, doi: 10.1007/BF01412787. L. K. Fung and W. M. Saltzman, “Polymeric implants for cancer chemotherapy,” Advanced Drug Delivery Reviews, vol. 26, no. 2-3, pp. 209-230, 1997, doi: 10.1016/S0169-409X(97)00036-7.
  3. J. Heller, R. W. Baker, R. M. Gale, and J. O. Rodin, “Controlled drug release by polymer dissolution. I. Partial esters of maleic anhydride copolymers—properties and theory,” J. Appl. Polym. Sci., vol. 22, no. 7, pp. 1991–2009, 1978. J. Heller, “Controlled release of biologically active compounds from bioerodible polymers,” Biomaterials, vol. 1, no. 1, pp. 51-57, 1980, doi: 10.1016/0142-9612(80)90060-5. K. R. Kamath and K. Park, “Biodegradable hydrogels in drug delivery,” Adv. Drug Deliv. Rev., vol. 11, no. 1-2, pp. 59-84, 1993, doi: 10.1016/0169-409X(93)90027-2. U. Edlund and A. C. Albertsson, “Degradable polymer microspheres for controlled drug delivery,”in Degradable Aliphatic Polyesters, Advances in Polymer Science, Springer, Berlin, Heidelberg, vol. 157, pp. 67-112, 2002, doi: 10.1007/3-540-45734-8_3. J. Yao, S. Zhang, W. Li, Z. Du, and Y. Li, “In vitro drug controlled-release behavior of an electrospun modified poly (lactic acid)/bacitracin drug delivery system,” RSC Adv., vol. 6, no. 1, pp. 515–521, 2016.
  4. M. A. Repka, S. Prodduturi, M. Munjal, and P. Mididoddi, “Matrix-and reservoir-based transmucosal delivery systems: tailoring delivery solutions,” Am. J. Drug Deliv., vol. 2, pp. 173–192, 2004.
  5. D. Cai, B. Zhang, J. Zhu, H. Xu, P. Liu, Z. Wang, J. Li, Z. Yang, X. Ma, and S. Chen, “Enhanced bacitracin production